Clinical Research on a Novel Deep-learning Based System in Pancreatic Endoscopic Ultrasound Scanning

Launched by THE THIRD XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY · Mar 29, 2023

Keywords

ClinConnect Summary

This clinical trial is exploring a new artificial intelligence (AI) system designed to assist doctors during pancreatic endoscopic ultrasound (EUS) scans. The main goals are to see how well this AI can recognize images compared to experienced ultrasound doctors and whether it can help make the scanning process faster and more efficient. Participants will receive an ultrasound of the pancreas, either with the help of the AI system or without it.

To be eligible for this study, you should be between 18 and 80 years old and need a pancreatic ultrasound. You must also be able to agree to participate and sign a consent form. However, if you have certain health issues, such as severe heart problems or are currently pregnant, you may not qualify. If you take part in the trial, you can expect to receive careful monitoring and support throughout the process as researchers gather important information to improve pancreatic care in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Age ≥18 years old, \<80 years old 2.Patients who need endoscopic ultrasonography of pancreas; 3. Agree to participate in this study and sign the informed consent form.
• Exclusion Criteria:
• * Subjects who meet any of the following criteria cannot be selected for this trial:
• First. The patient's physical condition does not meet the requirements of conventional endoscopic ultrasonography:
• • 1. Poor physical condition, including hemoglobin ≤8.0g/dl, severe cardiopulmonary insufficiency, etc.
• • 2. Anesthesia assessment failed
• • 3. Pregnancy or breastfeeding
• • 4. In the acute stage of chemical and corrosive injury, it is very easy to cause perforation
• • 5. Recent acute coronary syndrome or clinically unstable ischemic heart attack
• • 6. Heart disease patients with right-to-left shunt, patients with severe pulmonary hypertension (pulmonary artery pressure\> 90mmHg),patients with uncontrolled systemic hypertension and patients with adult respiratory distress syndrome.
• • Second. Disagree to participate in this study.
• Third. There are other problems that do not meet the requirements of this research or that affect the results of the research:
• • 1. Pancreatic disease has undergone surgery or radiotherapy and chemotherapy beforehand;
• • 2. Mental illness, drug addiction, inability to express themselves or other diseases that may affect follow-up.